Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12613000287730
Ethics application status
Approved
Date submitted
5/03/2013
Date registered
12/03/2013
Date last updated
12/03/2013
Type of registration
Retrospectively registered
Titles & IDs
Public title
Effectiveness of high intensity exercise training and vibration recovery on key health outcomes and weight control in overweight/obese people
Query!
Scientific title
Effectiveness of high intensity exercise training and vibration recovery on key health outcomes and weight control in overweight/obese people
Query!
Secondary ID [1]
282067
0
None
Query!
Universal Trial Number (UTN)
U1111-1140-1566
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
overweight/obese people
288554
0
Query!
Condition category
Condition code
Metabolic and Endocrine
288883
288883
0
0
Query!
Metabolic disorders
Query!
Physical Medicine / Rehabilitation
288884
288884
0
0
Query!
Other physical medicine / rehabilitation
Query!
Diet and Nutrition
288904
288904
0
0
Query!
Obesity
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Arm 1: High Intensity Interval Training (HIIT; 6 sets and then progressively increased to 10 sets over time x 1 min of high intensity aerobic training cycling on a stationary ergometer at 90%Heart rate Max) followed by 4 min of pasive recovery after each of the 1 min sets.
Arm 2: the same HIIT followed by vibration recovery (1 min of inter-set recovery at a frequency of 25 Hz and a peak to peak displacement of 4 mm).
In both groups caloric intake (55% complex carbohydrates, 30% fat, and 15% protein) will be reduced to obtain a negative balance of 500 kcal/day. The training sessions will be performed three times a week for 8 weeks and in all cases one-on-one supervised by an exercise physiologist
Query!
Intervention code [1]
286666
0
Rehabilitation
Query!
Intervention code [2]
286676
0
Lifestyle
Query!
Intervention code [3]
286677
0
Treatment: Other
Query!
Comparator / control treatment
Arm 3:Usual-care control group that will continue with their daily activities (without structured exercise) and with a negative balance of 500 kcal/day.
Query!
Control group
Active
Query!
Outcomes
Primary outcome [1]
289015
0
Insulinemia and HOMA index calculated as fasting serum insulin level (Milliunits per Liter) multiplied by fasting plasma glucose level (mmol/l)/22.5.
Biochemical determinations will be always carried out in
blood drawn in the morning after an overnight fast of 12 h.
Blood samples were cooled in ice water and immediately
centrifuged at 1000g for 45 min at 48C.
Query!
Assessment method [1]
289015
0
Query!
Timepoint [1]
289015
0
Baseline and after 8-week intervention
Query!
Primary outcome [2]
289016
0
Body composition (percentage of body fat and fat-free mass) assessed by means of Bio-electrical impedance using Bodystat Copyright 1500 analyzer (Bodystat Ltd, Douglas, Isle of Man, UK).
Query!
Assessment method [2]
289016
0
Query!
Timepoint [2]
289016
0
Baseline and after the 8-week intervention
Query!
Secondary outcome [1]
301566
0
waist circumference
Query!
Assessment method [1]
301566
0
Query!
Timepoint [1]
301566
0
at baseline and end-of-study (at 8 weeks).
Query!
Secondary outcome [2]
301567
0
body mass index (BMI)
Query!
Assessment method [2]
301567
0
Query!
Timepoint [2]
301567
0
at baseline and end-of-study (at 8 weeks).
Query!
Secondary outcome [3]
301568
0
resting blood pressure assessed using automatic sphygmomanometer
Query!
Assessment method [3]
301568
0
Query!
Timepoint [3]
301568
0
baseline and end-of-study (at 8 weeks).
Query!
Secondary outcome [4]
301569
0
Triglycerides, total, HDL and LDL cholesterol. Serum assay using Reflotron plus (Reflotron Registered Trademark plus, Bio-Stat Diagnostic Systems, Pepper Road, Hazel Grove, Strockport, Cheshire SK7 5BW (USA).
Query!
Assessment method [4]
301569
0
Query!
Timepoint [4]
301569
0
baseline and end-of-study (at 8 weeks).
Query!
Secondary outcome [5]
301570
0
High sensitivity-C-reactive protein. Serum assay using Reflotron plus (Reflotron Registered Trademark plus, Bio-Stat Diagnostic Systems, USA).
Query!
Assessment method [5]
301570
0
Query!
Timepoint [5]
301570
0
baseline and end-of-study (at 8 weeks).
Query!
Secondary outcome [6]
301572
0
Fitness (6-min walk test, hand-grip strength -using a Takei dynamometer- and lower-limb strength -measured by a load cell (Model 333A) connected to an A/D converting system (MuscleLab Registered Trademark, Ergotest AS, Langesund, Norway-)
Query!
Assessment method [6]
301572
0
Query!
Timepoint [6]
301572
0
Baseline and after 8 week intervention
Query!
Eligibility
Key inclusion criteria
a) BMI greater than or equal to 25 kg/m2
b) Sedentary participants (determined by means of the International Questionnaire of Physical Activity)
Query!
Minimum age
20
Years
Query!
Query!
Maximum age
50
Years
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Exclusion criteria include history or evidence of advanced cardiovascular (including SBP > 160 mmHG and DBP > 100 mmHG), renal or hepatic diseases, retinopathy, nephropathy, or neuropathy, orthopedic or other limitations that may interfere with their ability to exercise safely. Participants with Type I or II diabetes also will be excluded. Moreover, participants receiving physical therapy were excluded to avoid possible interactions with the present intervention.
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Not Applicable
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Recruiting
Query!
Date of first participant enrolment
Anticipated
1/02/2013
Query!
Actual
1/02/2013
Query!
Date of last participant enrolment
Anticipated
31/03/2013
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
50
Query!
Accrual to date
Query!
Final
Query!
Recruitment outside Australia
Country [1]
4897
0
Spain
Query!
State/province [1]
4897
0
Seville
Query!
Funding & Sponsors
Funding source category [1]
286842
0
University
Query!
Name [1]
286842
0
Department of Physical Education and Sport. University of Seville
Query!
Address [1]
286842
0
Facultad Ciencias de la Educacion. c/ Pirotecnia s/n. E-41013. Seville (Spain)
Query!
Country [1]
286842
0
Spain
Query!
Primary sponsor type
University
Query!
Name
University of Seville
Query!
Address
Facultad de Ciencias de la Educacion. C/ Pirotecnia s/n. E- 41013. Seville
Query!
Country
Spain
Query!
Secondary sponsor category [1]
285631
0
None
Query!
Name [1]
285631
0
Query!
Address [1]
285631
0
Query!
Country [1]
285631
0
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
288907
0
University of Seville
Query!
Ethics committee address [1]
288907
0
Vicerrectorado de Investigacion. Universidad de Sevilla. Pabellon de Brasil. Paseo de las Delicias s/n. Sevilla
Query!
Ethics committee country [1]
288907
0
Spain
Query!
Date submitted for ethics approval [1]
288907
0
25/01/2013
Query!
Approval date [1]
288907
0
01/03/2013
Query!
Ethics approval number [1]
288907
0
Query!
Summary
Brief summary
Exercise plays a key role in the prevention and treatment of overweight and reduction of body weight by lifestyle intervention is often modest. High intensity interval training (HIIT) characterized by repeated efforts at near-maximal to supramaximal work rates, interspersed with periods of recovery, has recently been used as an alternative to traditional endurance training to alter cardiorespiratory fitness and muscle metabolism. However, the optimal prescription with regards to intensity, work and rest duration, and number of intervals have yet to be elucidated. Alternatively, whole body vibration (WBV), which is a novel training intervention, has been proven to be a safe and effective exercise modality for improving body composition and muscle strength in deconditioned individuals. Numerous studies have indicated that WBV can decrease fat mass and increase muscle mass but also upregulate the nitric oxide dilator system and improve endothelial function which may indicate that WBV may be an effective intervention for improving health-related outcomes. To our knowledge this is the first study designed to combine both therapies; consequently, the aim of this study was to extend the previous findings examining the effects of short-term HIIT on overweight/obese people. Secondly, to determine whether vibration recovery lead to additional benefits in this population group. Methods: Fifty participants will be randomly assigned to either a HIIT training group with vibration recovery (WBVT), HIIT training group with passive recovery (HIIT) or usual-care control group (CON). Body composition (waist circumference, waist to hip ratio –WHR-, weight, height, percentage of body fat and fat-free mass), heart rate (HR), lipid-related cardiovascular risk factors (i.e. cholesterol, triglycerides, HDL, LDL, LDL/HDL and atherogenic index), Insulinemia and HOMA-index, high sensitivity-C-reactive protein and functional capacity as measured by time 6-minute walking test, hand-grip strength and lower-limb maximal strength will be assessed at baseline and after 8-weeks. Since all patients were overweight or obese, caloric intake (55% complex carbohydrates, 30% fat, and 15% protein) will be reduced to obtain a negative balance of 500 kcal/day. Requirements will be calculated by adding the estimated energy expenditure from PA to basal metabolism. WBVT participants will perform 6-10 sets x 1 min of HIIT at 90% heart rate max) followed by 6-10 x 1 min of inter-set vibration recovery at a frequency of 25 Hz and a peak to peak displacement of 4 mm. HIIT groups will perform the same HIIT followed by 4 min of passive recovery while the control group will continue their daily activities with the nutritional advice. As WBV increases leg blood flow and reduces fat mass, we hypothesize that it would provide additional therapeutic benefits to people with overweight characterized by impeded leg blood flow and abdominal obesity.
Query!
Trial website
Query!
Trial related presentations / publications
Query!
Public notes
Query!
Contacts
Principal investigator
Name
38290
0
Dr Borja Sanudo
Query!
Address
38290
0
Department of Physical Education and Sport. University of Seville. C/ Pirotecnia s/n. E-41013. Seville
Query!
Country
38290
0
Spain
Query!
Phone
38290
0
+34652387090
Query!
Fax
38290
0
Query!
Email
38290
0
[email protected]
Query!
Contact person for public queries
Name
38291
0
Borja Sanudo
Query!
Address
38291
0
Department of Physical Education and Sport. University of Seville. C/ Pirotecnia s/n. E-41013. Seville
Query!
Country
38291
0
Spain
Query!
Phone
38291
0
+34652387090
Query!
Fax
38291
0
Query!
Email
38291
0
[email protected]
Query!
Contact person for scientific queries
Name
38292
0
Borja Sanudo
Query!
Address
38292
0
Department of Physical Education and Sport. University of Seville. C/ Pirotecnia s/n. E-41013. Seville
Query!
Country
38292
0
Spain
Query!
Phone
38292
0
+34652387090
Query!
Fax
38292
0
Query!
Email
38292
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
No additional documents have been identified.
Download to PDF